SHCM
AGN

Sachem Head Capital Management’s Allergan plc AGN Stock Holding History

Sachem Head Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,365,000
Closed -$242M – 21
2020
Q1 		$242M Buy
1,365,000
+100,000
+8% +$18.8M 23.49% 1
2019
Q4 		$242M Hold
1,265,000
– – 18.98% 2
2019
Q3 		$213M Buy
+1,265,000
New +$206M 16.67% 2
2019
Q2 		– Sell
-775,000
Closed -$113M – 12
2019
Q1 		$113M Buy
+775,000
New +$112M 6.9% 8
2016
Q4 		– Sell
-495,000
Closed -$114M – 16
2016
Q3 		$114M Sell
495,000
-165,000
-25% -$40.3M 5.63% 6
2016
Q2 		$153M Sell
660,000
-895,000
-58% -$206M 6.75% 5
2016
Q1 		$417M Sell
1,555,000
-130,000
-8% -$37.2M 15.62% 3
2015
Q4 		$527M Buy
1,685,000
+230,000
+16% +$68.5M 16.66% 3
2015
Q3 		$395M Buy
1,455,000
+480,000
+49% +$147M 17.85% 2
2015
Q2 		$296M Buy
975,000
+175,000
+22% +$52.2M 19.86% 2
2015
Q1 		$238M Hold
800,000
– – 15.77% 2
2014
Q4 		$206M Buy
800,000
+425,000
+113% +$106M 15.32% 2
2014
Q3 		$90.5M Buy
+375,000
New +$83.9M 10.09% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Sachem Head Capital Management's AGN Position: Q2 2020 in Review

Sachem Head Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,365,000 shares — an estimated $242M sold.

Sachem Head Capital Management first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $527M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sachem Head Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Sachem Head Capital Management sold 1,365,000 Allergan plc shares in Q2 2020, an estimated $242M.
  • Sachem Head Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Sachem Head Capital Management's Allergan plc position peaked at $527M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sachem Head Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.